PD 0200390 Dose-ranging Trial: A Randomized, Double-blind, Placebo-controlled, 5-way Crossover, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia.

Trial Profile

PD 0200390 Dose-ranging Trial: A Randomized, Double-blind, Placebo-controlled, 5-way Crossover, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Jul 2012

At a glance

  • Drugs Atagabalin (Primary)
  • Indications Insomnia
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Oct 2009 Actual patient number changed from 83 to 92 as reported by ClinicalTrials.gov.
    • 17 Jul 2008 Actual end date (Jan 2008) added as reported by ClinicalTrials.gov.
    • 15 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top